Volume 10, Issue 4, Pages (April 1999)

Slides:



Advertisements
Similar presentations
Volume 7, Issue 5, Pages (November 1997)
Advertisements

Volume 39, Issue 3, Pages (September 2013)
Volume 9, Issue 5, Pages (November 1998)
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Regulation of Mast Cell Survival by IgE
The Chemokine Receptor CXCR4 Is Required for the Retention of B Lineage and Granulocytic Precursors within the Bone Marrow Microenvironment  Qing Ma,
SHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis
Volume 13, Issue 5, Pages (November 2000)
Volume 18, Issue 6, Pages (June 2003)
Volume 16, Issue 2, Pages (February 2002)
Marc Hertz, David Nemazee  Immunity 
Volume 11, Issue 5, Pages (November 1999)
Volume 18, Issue 4, Pages (April 2003)
Volume 36, Issue 1, Pages (January 2012)
PU.1/Spi-B Regulation of c-rel Is Essential for Mature B Cell Survival
A Negative Regulatory Role for Ig-α during B Cell Development
Volume 15, Issue 6, Pages (December 2001)
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Volume 24, Issue 3, Pages (March 2006)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
Volume 20, Issue 1, Pages (January 2004)
Volume 26, Issue 5, Pages (May 2007)
Fyn Can Partially Substitute for Lck in T Lymphocyte Development
CD22 is a negative regulator of B-cell receptor signalling
Silvia Bolland, Roger N Pearse, Tomohiro Kurosaki, Jeffrey V Ravetch 
Volume 8, Issue 6, Pages (June 1998)
Volume 125, Issue 4, Pages (May 2006)
Volume 7, Issue 1, Pages (July 1997)
Volume 8, Issue 4, Pages (April 1998)
The Physiologic Role of CD19 Cytoplasmic Tyrosines
Volume 20, Issue 4, Pages (April 2004)
A Point Mutation in the Constant Region of Ig Lambda1 Prevents Normal B Cell Development due to Defective BCR Signaling  Tianhe Sun, Marcus R Clark, Ursula.
Regulation of Mast Cell Survival by IgE
Manfred Kraus, Kaoru Saijo, Raul M Torres, Klaus Rajewsky  Immunity 
Regulation of BCR Signal Transduction in B-1 Cells Requires the Expression of the Src Family Kinase Lck  Joseph M. Dal Porto, Kathy Burke, John C. Cambier 
Volume 7, Issue 1, Pages (July 1997)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 32, Issue 5, Pages (May 2010)
Volume 14, Issue 2, Pages (February 2001)
Siqi Lin, Claudia Cicala, Andrew M Scharenberg, Jean-Pierre Kinet  Cell 
Volume 19, Issue 4, Pages (October 2003)
Volume 27, Issue 3, Pages (September 2007)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Volume 26, Issue 1, Pages (January 2007)
Volume 17, Issue 5, Pages (November 2002)
Silva H Hanissian, Raif S Geha  Immunity 
Volume 13, Issue 1, Pages (July 2000)
Volume 11, Issue 2, Pages (August 1999)
LAT Links the Pre-BCR to Calcium Signaling
Volume 32, Issue 2, Pages (February 2010)
TRAF1 Is a Negative Regulator of TNF Signaling
Volume 14, Issue 1, Pages (January 2001)
Volume 16, Issue 10, Pages (September 2016)
Volume 28, Issue 5, Pages (May 2008)
Volume 17, Issue 3, Pages (September 2002)
A Function of Fas-Associated Death Domain Protein in Cell Cycle Progression Localized to a Single Amino Acid at Its C-Terminal Region  Zi Chun Hua, Sue.
Notch 1 Signaling Regulates Peripheral T Cell Activation
Renee Hackenmiller, Jynho Kim, Ricardo A. Feldman, M.Celeste Simon 
Volume 16, Issue 10, Pages (September 2016)
RhoA GTPase Regulates B Cell Receptor Signaling
Mary O'Riordan, Rudolf Grosschedl  Immunity 
Volume 31, Issue 5, Pages (November 2009)
Volume 10, Issue 2, Pages (February 1999)
Volume 28, Issue 1, Pages (January 2008)
Volume 12, Issue 6, Pages (March 2002)
Volume 25, Issue 4, Pages (October 2006)
Volume 13, Issue 21, Pages (October 2003)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Volume 10, Issue 4, Pages 399-408 (April 1999) PU.1 and Spi-B Are Required for Normal B Cell Receptor–Mediated Signal Transduction  Lee Ann Garrett-Sinha, Gloria H Su, Sridhar Rao, Shara Kabak, Zengping Hao, Marcus R Clark, M.Celeste Simon  Immunity  Volume 10, Issue 4, Pages 399-408 (April 1999) DOI: 10.1016/S1074-7613(00)80040-0

Figure 1 A B Cell Deficiency Is Present in PU.1+/−Spi-B−/− Mice (A and B) PU.1+/−Spi-B−/− mice exhibit fewer immature and mature B lymphocytes in the spleen and lymph nodes as compared to wild-type littermates (absolute numbers of B cells in spleen: wild-type 31.1 × 106 ± 1.7 × 106, PU.1+/−Spi-B−/− 15.9 × 106 ± 3.3 × 106 [p < 0.02], and lymph node: wild-type 2.8 × 106 ± 0.5 × 106, PU.1+/−Spi-B−/− 1.0 × 106 ± 0.1 × 106 [p < 0.07]). Flow cytometry performed on the indicated tissue specimens assayed B220/IgM and IgD/IgM staining. Differences in IgD staining between genotypes are largely due to differences in fluorescence intensity between the IgDa and IgDb antibodies used. Modest reductions in the numbers of IgM+IgD− and IgM+IgD+ B cells were detected in 30% of the PU.1+/−Spi-B+/− animals. (C) PU.1+/−Spi-B−/− mice produce normal numbers of pro-B and pre-B cells. FACs analysis of total bone marrow cells showed that the number of B220+S7+ (pro-B) cells in PU.1+/−Spi-B−/− mice was normal, whereas the number of B220+S7− (comprising to the pre-B, immature B, and mature recirculating B) cells was reduced. To further define the developmental stage at which differences were noted, B220/BP-1 staining was performed. PU.1+/−Spi-B−/− mice showed normal numbers of B220+BP-1+ (pro- and pre-B) cells but reduced numbers of B220+BP-1− (immature and mature recirculating B) cells. Differences in the total number of B220+ cells between panels is due to the fact that different mice were used in the two experiments. To confirm stage at which B cell numbers were reduced, three-color FACs analyses were performed. The B220+S7− population was gated and is shown in (D). The majority of the B220+S7− cells in PU.1+/−Spi-B−/− bone marrow are B220intIgM− and B220intHSAhi, signifying the presence of pre-B cells at the expense of more differentiated cell types. B220hiIgM+HSAlo immature and mature B cells represent a minor population in the PU.1+/−Spi-B−/− bone marrow. These results are consistent with the presence of normal numbers of B220+BP-1+ pro- and pre-B cells in mutant bone marrow, shown in (D). (E) Mutant B cells express increased levels of surface IgM. Purified splenic B cells from PU.1+/+Spi-B+/+, PU.1+/−Spi-B+/−, PU.1+/+Spi-B−/−, and PU.1+/−Spi-B−/− mice were stained with IgM-FITC and analyzed by flow cytometry. The peak fluorescence intensity for each sample (indicated by the numbers in the upper right corner) shows that B cells from PU.1+/+Spi-B−/− and PU.1+/−Spi-B−/− mice on average express higher levels of surface IgM than B cells from PU.1+/+Spi-B+/+ or PU.1+/−Spi-B+/− mice. Immunity 1999 10, 399-408DOI: (10.1016/S1074-7613(00)80040-0)

Figure 2 IgM+IgD− and IgM+IgD+ B Lymphocytes in PU.1+/−Spi-B−/− Spleen Exhibit High Levels of Apoptosis Spleen cells were stained with IgM (cychrome) and IgD (PE), incubated with Annexin V (FITC), and analyzed by flow cytometry. IgM+IgD− and IgM+IgD+ populations were gated. Increased rates of apoptosis were observed for both immature and mature B cells in spleens obtained from PU.1+/−Spi-B−/− animals. Immunity 1999 10, 399-408DOI: (10.1016/S1074-7613(00)80040-0)

Figure 3 PU.1+/−Spi-B−/− Mice Fail to Form Germinal Centers Spleen sections were obtained from PU.1+/+Spi-B+/+ (A and B), PU.1+/+Spi-B−/− (C and D), PU.1+/−Spi-B+/− (E and F), and PU.1+/−Spi-B−/− mice (G and H) at day 10 (A, C, E, and G) and day 28 (B, D, F, and H) post DNP-KLH immunization and stained with peanut agglutinin (PNA). PNA+ germinal center B cells appear as dark brown areas as indicated by the white arrows. Immunity 1999 10, 399-408DOI: (10.1016/S1074-7613(00)80040-0)

Figure 4 B Cell Proliferative Responses Assayed In Vitro Splenic B cells were isolated from PU.1+/+Spi-B+/+ (white bars), PU.1+/−Spi-B+/− (gray bars), PU.1+/+Spi-B−/− (striped bars), and PU.1+/−Spi-B−/− (black bars) animals and stimulated with the indicated mitogens. Data are represented as the mean and standard error of at least four independent experiments. (A) B cells were stimulated with 50 μg/ml F(ab’)2 fragment of anti-IgM antibody, 50 μg/ml LPS, or 10 ng/ml PMA and 0.5 μg/ml ionomycin. (B) B cells were stimulated with suboptimal amounts (3 μg/ml) of F(ab’)2 fragment of anti-IgM antibody alone or in combination with 10 μg/ml anti-CD40 antibodies or 10 ng/ml recombinant IL-4. Immunity 1999 10, 399-408DOI: (10.1016/S1074-7613(00)80040-0)

Figure 6 Model of BCR-Mediated Signal Transduction A simplified model of some of the known components involved in the membrane-proximal steps of BCR signaling. Membrane bound IgM in association with Igα and Igβ constitutes the BCR complex. Src family kinases phosphorylate the ITAM motifs of Igα and Igβ. Syk then binds to the phospho-ITAMs via its SH2 domains and interacts with downstream targets including BLNK and PLCγ. We theorize that Spi-B−/− and PU.1+/−Spi-B−/− B cells lack expression of some critical component X, which is required for coupling downstream proteins to syk. Immunity 1999 10, 399-408DOI: (10.1016/S1074-7613(00)80040-0)

Figure 5 Mutant B Cells Exhibit Reduced BCR Signaling Protein extracts of splenic B cells purified from mice with the indicated genotypes were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and probed with the anti-phosphotyrosine mAb 4G10. Prior to lysis, B cells were either mock stimulated with media or stimulated with 50 μg/ml F(ab’)2 fragment of anti-IgM antibody for the indicated times (A) or 2.5 mM Na3VO4/0.3% H2O2 for 1 min (B). (C) Purified splenic B cells were incubated with the Ca2+-sensitive dyes Fluo-3 and Fura-Red. Basal fluorescence ratios of cells at 37°C were measured for 30 s. Anti-IgM antibody was added to 50 μg/ml, and fluorescence changes were measured for an additional 4 min. Results are represented in arbitrary units as changes in fluorescence ratio over time. (D) Lysates from purified splenic B cells were immunoprecipitated with the indicated antibodies. Immunoprecipitates were Western blotted using the anti-phosphotyrosine antibody 4G10. Blots were then stripped and reprobed with the indicated antibodies. The decrease in syk phosphorylation exhibited by PU.1+/−Spi-B−/− B cells compared to wild-type cells was not reproducible, whereas decreases in the phosphorylation of BLNK and PLCγ2 were. Immunity 1999 10, 399-408DOI: (10.1016/S1074-7613(00)80040-0)